BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 8293765)

  • 21. Endogenous nitric oxide attenuates beta-adrenoceptor-mediated relaxation in rat aorta.
    Kang KB; van der Zypp A; Majewski H
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):95-101. PubMed ID: 17201742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.
    Kauffman RF; Schenck KW; Utterback BG; Crowe VG; Cohen ML
    J Pharmacol Exp Ther; 1987 Sep; 242(3):864-72. PubMed ID: 2821228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure.
    Toyoshima H; Nasa Y; Kohsaka Y; Isayama Y; Yamaguchi F; Sanbe A; Takeo S
    Br J Pharmacol; 1998 Jan; 123(2):344-52. PubMed ID: 9489624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM; Cheng ZJ; Kuo SC
    Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
    Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelium-dependent and -independent vasorelaxation by a theophylline derivative MCPT: roles of cyclic nucleotides, potassium channel opening and phosphodiesterase inhibition.
    Lo YC; Tsou HH; Lin RJ; Wu DC; Wu BN; Lin YT; Chen IJ
    Life Sci; 2005 Jan; 76(8):931-44. PubMed ID: 15589969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery.
    Yeung DK; Leung SW; Xu YC; Vanhoutte PM; Man RY
    Eur J Pharmacol; 2006 Dec; 552(1-3):105-11. PubMed ID: 17027964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta.
    Andriambeloson E; Kleschyov AL; Muller B; Beretz A; Stoclet JC; Andriantsitohaina R
    Br J Pharmacol; 1997 Mar; 120(6):1053-8. PubMed ID: 9134217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
    Pagani ED; Dundore RL; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential phosphodiesterase activity contributes to restrictive endothelial barrier function during angiogenesis.
    DeFouw LM; DeFouw DO
    Microvasc Res; 2001 Nov; 62(3):263-70. PubMed ID: 11678629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
    Oelke M; Hedlund P; Albrecht K; Ellinghaus P; Stief CG; Jonas U; Andersson KE; Uckert S
    Urology; 2006 May; 67(5):1111-6. PubMed ID: 16635522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of phosphodiesterase isozymes to the regulation of the L-type calcium current in human cardiac myocytes.
    Kajimoto K; Hagiwara N; Kasanuki H; Hosoda S
    Br J Pharmacol; 1997 Aug; 121(8):1549-56. PubMed ID: 9283687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.
    Chiu JH; Chen KK; Chien TM; Chiou WF; Chen CC; Wang JY; Lui WY; Wu CW
    Int J Impot Res; 2006; 18(4):335-42. PubMed ID: 16395327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostacyclin-induced relaxations of small porcine pulmonary arteries are enhanced by the basal release of endothelium-derived nitric oxide through an effect on cyclic GMP-inhibited-cyclic AMP phosphodiesterase.
    Zellers TM; Wu YQ; McCormick J; Vanhoutte PM
    Acta Pharmacol Sin; 2000 Feb; 21(2):131-8. PubMed ID: 11263259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of membrane-bound cyclic nucleotide phosphodiesterases from bovine aortic smooth muscle.
    Ivorra MD; Le Bec A; Lugnier C
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):532-40. PubMed ID: 1380595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of phosphodiesterases in the regulation of endothelial permeability in vitro.
    Suttorp N; Weber U; Welsch T; Schudt C
    J Clin Invest; 1993 Apr; 91(4):1421-8. PubMed ID: 8386187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
    Priviero FB; Teixeira CE; Toque HA; Claudino MA; Webb RC; De Nucci G; Zanesco A; Antunes E
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):448-55. PubMed ID: 16700877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphodiesterase isoenzymes in human ureteral smooth muscle: identification, characterization, and functional effects of various phosphodiesterase inhibitors in vitro.
    Stief CG; Taher A; Truss M; Becker AJ; Schulz-Knappe P; Meyer M; Uckert S; Forssmann WG; Jonas U
    Urol Int; 1995; 55(4):183-9. PubMed ID: 8588263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.